• Artrya secures 3-year commercial contract with Sonic Healthcare Australia
• Contract will generate revenue through a Software-as-a-Service (SaaS) subscription model
• Sonic Healthcare is the second-largest radiology diagnostic imaging group in Australia

Artrya Limited, a medical technology company focused on commercialising its patented artificial intelligence platform that detects key coronary artery disease imaging markers, has secured a three-year commercial agreement with Sonic Healthcare Australia - Radiology for the use of its Salix® Coronary Anatomy platform. Sonic Healthcare is a globally recognised healthcare provider and the second-largest radiology diagnostic imaging group in Australia, managing over 125 radiology centres and a network of 1,800 radiologists and pathologists. Under the agreement, Salix will be integrated into all Sonic Healthcare Radiology centres that perform Coronary Computed Tomography Angiography (CCTA) scans for coronary heart disease detection. Salix is designed to enhance accuracy and efficiency in detecting stenoses and other critical markers, including high-risk plaque from CCTA scans, whilst also optimizing clinical workflow. The contract will generate revenue through a Software-as-a-Service (SaaS) subscription model, with initial revenue anticipated in Q4 FY25.

Artrya is using the Australian market as an excellent environment to test its software and obtain valuable clinical information, in preference to generating material revenue from the Australian market.